Stocks News

LAST PRICE
62.6600
TODAY'S CHANGE (%)
Trending Down-0.8600 (-1.3539%)

Bid / Lots
61.5200/ 1
Ask / Lots
64.5000/ 1
Open / Previous Close
63.2100 / 63.5200
Day Range
Low 61.7900
High 63.3100
52 Week Range
Low 51.7900
High 89.9100
Volume
965,762
average

Search Criteria

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
Company	Country	Symbol

TD Direct Investing offers more research reports than any other discount brokerage in Canada. Provided from the industry's most trusted sources, our service includes timely, relevant information for the current trading day and comprehensive industry, sector, and insider trading reports for further analysis.

Open a New Account, or Login if you're a client.

Apr 23, 2024
- Bio-Techne Says It Filed Patent Infringement Lawsuit Against Molecular Instruments in Europe, from 9:16AM ET on Tuesday Apr 23, 2024 by MT Newswires
  9:16AM ET on Tuesday Apr 23, 2024 by MT Newswires
  Companies Mentioned: TECH
  09:16 AM EDT, 04/23/2024 (MT Newswires) -- Bio-Techne (TECH) said Tuesday it has filed a lawsuit against Molecular Instruments in the Unified Patent Court in Europe over the alleged infringement of its patented RNAscope ISH technology. The company c...
- BIO-TECHNE FILES PATENT INFRINGEMENT LAWSUIT AGAINST MOLECULAR INSTRUMENTS, from 7:00AM ET on Tuesday Apr 23, 2024 by Dow Jones
  7:00AM ET on Tuesday Apr 23, 2024 by Dow Jones
  Companies Mentioned: TECH
  
  BIO-TECHNE FILES PATENT INFRINGEMENT LAWSUIT AGAINST MOLECULAR INSTRUMENTS
  
  PR Newswire
  
  MINNEAPOLIS, April 23, 2024
  
  Bio-Techne enforces intellectual property for gold standard RNAscope(R) ISH technology in spatial biology research and clinical applications.
Apr 18, 2024
- DJ Bio-Techne Is Maintained at Buy by Deutsche Bank, from 8:21AM ET on Thursday Apr 18, 2024 by Dow Jones
  8:21AM ET on Thursday Apr 18, 2024 by Dow Jones
  Companies Mentioned: TECH
  
  Ratings actions from Benzinga: https://www.benzinga.com/quote/TECH/analyst-ratings
  
  (END) Dow Jones Newswires
  
  April 18, 2024 08:21 ET (12:21 GMT)
- --Deutsche Bank Adjusts Bio-Techne Price Target to $82 From $85, from 7:21AM ET on Thursday Apr 18, 2024 by MT Newswires
  7:21AM ET on Thursday Apr 18, 2024 by MT Newswires
  Companies Mentioned: TECH
  07:21 AM EDT, 04/18/2024 (MT Newswires) -- (MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www.mtnewswires.com/contac...
Apr 10, 2024
- BIO-TECHNE TO HOST CONFERENCE CALL ON MAY 1, 2024, TO ANNOUNCE THIRD QUARTER FISCAL 2024 FINANCIAL RESULTS, from 7:00AM ET on Wednesday Apr 10, 2024 by Dow Jones
  7:00AM ET on Wednesday Apr 10, 2024 by Dow Jones
  Companies Mentioned: TECH
  
  BIO-TECHNE TO HOST CONFERENCE CALL ON MAY 1, 2024, TO ANNOUNCE THIRD QUARTER FISCAL 2024 FINANCIAL RESULTS
  
  PR Newswire
  
  MINNEAPOLIS, April 10, 2024
  
  MINNEAPOLIS, April 10, 2024 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced that management will host a conference call and webcast on Wednesday, May 1, 2024, at 8:00 a.m. CDT to review third quarter fiscal 2024 financial results.

Yesterday
- European Equities Traded in the US as American Depositary Receipts Trend Modestly Higher in Thursday Trading, from 13 hours ago by MT Newswires
  13 hours ago by MT Newswires
  Companies Mentioned: AVDL, SNY, TRIB, UL, NCNA, AUTL, OPRA, AZN, BCS, CALT, BPTS, TCBP, ASND, CLLS, BDRX, EDAP
- Ionis Publishes 2023 Corporate Responsibility Report, from 17 hours ago by PR Newswire
  17 hours ago by PR Newswire
  Companies Mentioned: IONS
Apr 24, 2024
- Ascendis Pharma Gets UK Regulator's Approval for Yorvipath to Treat Hypoparathyroidism, from 11:33AM ET on Wednesday Apr 24, 2024 by MT Newswires
  11:33AM ET on Wednesday Apr 24, 2024 by MT Newswires
  Companies Mentioned: ASND
Apr 23, 2024
- Ionis to hold first quarter 2024 financial results webcast, from 7:05AM ET on Tuesday Apr 23, 2024 by PR Newswire
  7:05AM ET on Tuesday Apr 23, 2024 by PR Newswire
  Companies Mentioned: IONS
Apr 19, 2024
- European Equities Traded in the US as American Depositary Receipts Trend Higher in Friday Trading But End Week Down, from 11:10AM ET on Friday Apr 19, 2024 by MT Newswires
  11:10AM ET on Friday Apr 19, 2024 by MT Newswires
  Companies Mentioned: SQNS, NCNA, AMRN, AUTL, OPRA, DAVA, BCYC, CALT, SLN, BPTS, BP, DBVT, ASND, CLLS, ADAP, EDAP
Apr 18, 2024
- European Equities Traded in the US as American Depositary Receipts Flat in Thursday Trading, from 11:08AM ET on Thursday Apr 18, 2024 by MT Newswires
  11:08AM ET on Thursday Apr 18, 2024 by MT Newswires
  Companies Mentioned: NTZ, VEON, SNY, TRIB, SQNS, AMRN, AUTL, OPRA, DAVA, BCYC, CRTO, TCBP, ASND, ADAP, BDRX, E
Apr 10, 2024
- Wolfe Research Upgrades Ionis Pharmaceuticals to Outperform From Peer Perform, from 8:11AM ET on Wednesday Apr 10, 2024 by MT Newswires
  8:11AM ET on Wednesday Apr 10, 2024 by MT Newswires
  Companies Mentioned: IONS
Apr 9, 2024
- Oppenheimer Raises Ionis Pharmaceuticals' Price Target to $75 From $72, Maintains Outperform Rating, from 9:08AM ET on Tuesday Apr 09, 2024 by MT Newswires
  9:08AM ET on Tuesday Apr 09, 2024 by MT Newswires
  Companies Mentioned: IONS
Apr 7, 2024
- Ionis presents positive results from Phase 3 Balance study of olezarsen for familial chylomicronemia syndrome, from 9:48AM ET on Sunday Apr 07, 2024 by PR Newswire
  9:48AM ET on Sunday Apr 07, 2024 by PR Newswire
  Companies Mentioned: IONS
Apr 3, 2024
- QIAGEN strengthens its portfolio for cancer research, showcasing latest product launches at AACR Annual Meeting 2024, from 4:05PM ET on Wednesday Apr 03, 2024 by GlobeNewswire
  4:05PM ET on Wednesday Apr 03, 2024 by GlobeNewswire
  Companies Mentioned: QGEN

Bio-Techne Corp
NASDAQ:TECHUnited States

Search Criteria

Apr 23, 2024

Bio-Techne Says It Filed Patent Infringement Lawsuit Against Molecular Instruments in Europe, from 9:16AM ET on Tuesday Apr 23, 2024 by MT Newswires

BIO-TECHNE FILES PATENT INFRINGEMENT LAWSUIT AGAINST MOLECULAR INSTRUMENTS, from 7:00AM ET on Tuesday Apr 23, 2024 by Dow Jones

Apr 18, 2024

DJ Bio-Techne Is Maintained at Buy by Deutsche Bank, from 8:21AM ET on Thursday Apr 18, 2024 by Dow Jones

--Deutsche Bank Adjusts Bio-Techne Price Target to $82 From $85, from 7:21AM ET on Thursday Apr 18, 2024 by MT Newswires

Apr 10, 2024

BIO-TECHNE TO HOST CONFERENCE CALL ON MAY 1, 2024, TO ANNOUNCE THIRD QUARTER FISCAL 2024 FINANCIAL RESULTS, from 7:00AM ET on Wednesday Apr 10, 2024 by Dow Jones

Peers Headlines

Yesterday

European Equities Traded in the US as American Depositary Receipts Trend Modestly Higher in Thursday Trading, from 13 hours ago by MT Newswires

Ionis Publishes 2023 Corporate Responsibility Report, from 17 hours ago by PR Newswire

Apr 24, 2024

Ascendis Pharma Gets UK Regulator's Approval for Yorvipath to Treat Hypoparathyroidism, from 11:33AM ET on Wednesday Apr 24, 2024 by MT Newswires

Apr 23, 2024

Ionis to hold first quarter 2024 financial results webcast, from 7:05AM ET on Tuesday Apr 23, 2024 by PR Newswire

Apr 19, 2024

European Equities Traded in the US as American Depositary Receipts Trend Higher in Friday Trading But End Week Down, from 11:10AM ET on Friday Apr 19, 2024 by MT Newswires

Apr 18, 2024

European Equities Traded in the US as American Depositary Receipts Flat in Thursday Trading, from 11:08AM ET on Thursday Apr 18, 2024 by MT Newswires

Apr 10, 2024

Wolfe Research Upgrades Ionis Pharmaceuticals to Outperform From Peer Perform, from 8:11AM ET on Wednesday Apr 10, 2024 by MT Newswires

Apr 9, 2024

Oppenheimer Raises Ionis Pharmaceuticals' Price Target to $75 From $72, Maintains Outperform Rating, from 9:08AM ET on Tuesday Apr 09, 2024 by MT Newswires

Apr 7, 2024

Ionis presents positive results from Phase 3 Balance study of olezarsen for familial chylomicronemia syndrome, from 9:48AM ET on Sunday Apr 07, 2024 by PR Newswire

Apr 3, 2024

QIAGEN strengthens its portfolio for cancer research, showcasing latest product launches at AACR Annual Meeting 2024, from 4:05PM ET on Wednesday Apr 03, 2024 by GlobeNewswire